Keywords: UCB, Neupro, Restless legs sydrome, RLS,

New data show sustained five-year benefit of UCB’s Neupro for RLS

Article | 14 April 2010

Print This

New data presented at the 62nd American Academy of Neurology annual meeting being held in Toronto, Canada, showed that patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in